Innovation Pharmaceuticals share#snapshot#suffix
| 0,00USD | 0,00USD | -99,00% |
WKN DE: A2DTBJ / ISIN: US45782D1000
Innovation Pharmaceuticals share#search#balancesheet/share#balance#headline#income_statement
share#balance#profitpershare- Innovation Pharmaceuticals
| 0,0 23 | 0,0 22 | 0,0 21 | 0,0 20 | 0,0 19 | -0,1 18 | -0,1 17 |
share#balance#salespershare- Innovation Pharmaceuticals
| 0 23 | 0,0 22 | 0 21 | 0,0 20 | 0 19 | 0 18 | 0 17 |
share#balance#p_e_ratio- Innovation Pharmaceuticals
Innovation Pharmaceuticals Inc Registered Shs: share#balance#headline#theshare (in USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie berichtet | -0,01 | -0,01 | -0,04 | -0,03 | -0,05 | -0,10 | -0,12 |
| Gewinn je Aktie unverwässert | -0,01 | -0,01 | -0,04 | -0,03 | -0,05 | -0,11 | -0,12 |
| Gewinn je Aktie verwässert | -0,01 | -0,01 | -0,04 | -0,03 | -0,05 | -0,11 | -0,12 |
| share#balance#cell#dividend_per_share | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| share#balance#cell#dividend_payment | 0,09 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | - |
Innovation Pharmaceuticals Inc Registered Shs: share#balance#business_ratio (in USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| share#balance#cell#sales_share | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| share#balance#cell#basic_kgv_end | - | - | - | - | - | - | - |
| share#balance#cell#diluted_kgv_end | - | - | - | - | - | - | - |
| share#balance#cell#dividend_ratio | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| share#balance#cell#equity_ratio | 27,13 | 45,57 | 52,51 | 15,81 | -102,05 | -32,88 | -16,07 |
| share#balance#cell#debt_ratio | 72,87 | 54,43 | 47,49 | 84,19 | 202,05 | 132,88 | 116,07 |
Innovation Pharmaceuticals Inc Registered Shs: share#balance#headline#income_statement (in Mio. USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| share#balance#cell#sales | 0,00 | 0,02 | 0,00 | 0,42 | 0,00 | 0,00 | 0,00 |
| share#balance#cell#sales_change | -100,00 | - | -100,00 | - | - | - | - |
| share#balance#cell#sales_gross_profit | -0,37 | -0,36 | -0,38 | - | -0,37 | -0,41 | -0,41 |
| share#balance#cell#sales_gross_profit_change | -2,47 | 3,70 | - | - | 10,17 | -1,72 | 3,33 |
| share#balance#cell#operating_income | -2,94 | -6,76 | -9,02 | -4,64 | -6,30 | -13,78 | -15,34 |
| share#balance#cell#operating_income_change | 56,51 | 25,04 | -94,50 | 26,39 | 54,30 | 10,15 | -27,74 |
| share#balance#cell#income_before_tax | -3,17 | -7,04 | -13,87 | -6,65 | -8,68 | -16,36 | -15,54 |
| share#balance#cell#income_before_tax_change | 55,01 | 49,24 | -108,66 | 23,42 | 46,94 | -5,32 | -20,88 |
| share#balance#cell#income_after_tax | -3,17 | -7,04 | -13,87 | -6,65 | -8,68 | -16,36 | -15,54 |
| share#balance#cell#income_after_tax_change | 55,01 | 49,24 | -108,66 | 23,42 | 46,94 | -5,32 | -20,88 |
Innovation Pharmaceuticals Inc Registered Shs: share#balance#headline#balance (in Mio. USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| share#balance#cell#total_liabilities | 5 | 6 | 7 | 8 | 8 | 9 | 11 |
| Langzeit Gesamtverbindlichk. pro Aktie | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| share#balance#cell#total_equity | 2 | 5 | 8 | 1 | -4 | -2 | -1 |
| share#balance#cell#total_equity_change | -56,89 | -37,01 | 413,61 | - | -91,96 | -46,93 | -149,39 |
| share#balance#cell#total_liabilities_and_equity | 8 | 10 | 14 | 9 | 4 | 7 | 9 |
| share#balance#cell#total_liabilities_and_equity_change | -27,57 | -27,41 | 54,62 | 128,57 | -38,14 | -28,22 | -20,38 |
Innovation Pharmaceuticals Inc Registered Shs: share#balance#headline#other_data (in USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | -0,01 | -0,01 | -0,04 | -0,03 | -0,05 | -0,11 | -0,12 |
| Veränderung Gewinn je Aktie (unverwässert) in % | 55,00 | 61,00 | -28,21 | 42,51 | 56,98 | 5,67 | -9,09 |
| Gewinn je Aktie (verwässert) | -0,01 | -0,01 | -0,04 | -0,03 | -0,05 | -0,11 | -0,12 |
| Veränderung Gewinn je Aktie (verwässert) in % | 55,00 | 61,00 | -28,21 | 42,51 | 56,98 | 5,67 | -9,09 |
| share#balance#cell#employees | 4 | 4 | 4 | 4 | 4 | 8 | 15 |
| share#balance#cell#employees_change | 0,00 | 0,00 | 0,00 | 0,00 | -50,00 | -46,67 | 0,00 |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.